Abstract
Recent advances in genome editing have brought new hopes for personalized and precision medicine but have also dramatically facilitated disease modeling studies. Combined with reprogramming approaches, stem cells and differentiation toward neural lineages, genome engineering holds great potential for regenerative approaches and to model neurological disorders. The use of patient-specific induced pluripotent stem cells combined with neural differentiation allows studying the effect of specific mutations in different brain cells. New genome editing tools such as CRISPR/Cas9 represent a step further by facilitating the introduction or correction of specific mutations within the same cell line, thus eliminating variability due to differences in the genetic background. Here, we present a step-by-step protocol from design to generation of human pluripotent stem cell lines with specific mutations introduced or corrected with CRISPR/Cas9 gene editing that can be used in combination with transcription factor-based protocols to dissect underlying mechanisms of neurological disorders.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 93(3):1156–1160
Christian M et al (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186(2):757–761
Ishino Y et al (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169(12):5429–5433
Hermans PW et al (1991) Insertion element IS987 from Mycobacterium bovis BCG IS located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect Immun 59(8):2695–2705
Mojica FJ, Juez G, Rodriguez-Valera F (1993) Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially modified PstI sites. Mol Microbiol 9(3):613–621
Jansen R et al (2002) Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 43(6):1565–1575
Bolotin A et al (2005) Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151(Pt 8):2551–2561
Mojica FJ et al (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60(2):174–182
Pourcel C, Salvignol G, Vergnaud G (2005) CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151(Pt 3):653–663
Barrangou R et al (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315(5819):1709–1712
Jinek M et al (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816–821
Cong L et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121):819–823
Paquet D et al (2016) Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533(7601):125–129
Yang L et al (2013) Optimization of scarless human stem cell genome editing. Nucleic Acids Res 41(19):9049–9061
Renaud JB et al (2016) Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases. Cell Rep 14(9):2263–2272
Okamoto S et al (2019) Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs. Sci Rep 9(1):4811
Ratz M et al (2015) CRISPR/Cas9-mediated endogenous protein tagging for RESOLFT super-resolution microscopy of living human cells. Sci Rep 5:9592
Yang G, Huang X (2019) Methods and applications of CRISPR/Cas system for genome editing in stem cells. Cell Regen (Lond) 8(2):33–41
Forrest MP et al (2017) Open chromatin profiling in hiPSC-derived neurons prioritizes functional noncoding psychiatric risk variants and highlights neurodevelopmental loci. Cell Stem Cell 21(3):305–318. e8
Deneault E et al (2019) CNTN5(−)(/+)or EHMT2(−)(/+)human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks. Elife 8:e40092
Lin YT et al (2018) APOE4 causes widespread molecular and cellular alterations associated with Alzheimer’s disease phenotypes in human iPSC-derived brain cell types. Neuron 98(6):1141–1154. e7
Valdez C et al (2017) Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Hum Mol Genet 26(24):4861–4872
Canals I et al (2018) Rapid and efficient induction of functional astrocytes from human pluripotent stem cells. Nat Methods 15(9):693–696
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Canals, I., Ahlenius, H. (2021). CRISPR/Cas9 Genome Engineering in Human Pluripotent Stem Cells for Modeling of Neurological Disorders. In: Ahlenius, H. (eds) Neural Reprogramming. Methods in Molecular Biology, vol 2352. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1601-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1601-7_16
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1600-0
Online ISBN: 978-1-0716-1601-7
eBook Packages: Springer Protocols